Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

Not Applicable

Completed

• Conditions: Non-Small Cell Lung Carcinoma; Small Cell Lung Cancer

• Registration Number: NCT00213798
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-12
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Status Verified: 2011-08
• Study Completion: 2011-08
• Last Update Submitted: 2011-08-29
• Last Update Posted: 2011-08-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.
• No lung instability.
• Individuals give all informed consent

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (4)

Service de Pneumologie, Hôpital Lyautey; 🇫🇷 Strasbourg, France

Service de Chirurgie Thoracique, Hôpital Civil; 🇫🇷 Strasbourg, France

Service de Pneumologie, Hôpital Civil; 🇫🇷 Strasbourg, France

Service de Pneumologie, Hôpital de Hautepierre; 🇫🇷 Strasbourg, France